WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark RHEACELL Innovative Stem Cell Therapies was filed as Word mark on 12/11/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1581960 |
| Register number | 302020013149 |
| Countries | 
|
| Base trademark |
No. 30 2020 013 149,
November 10, 2020
|
| Application date | December 11, 2020 |
| Expiration date | December 11, 2030 |
Trademark owner
Im Neuenheimerfeld 517
69120 Heidelberg
DE
69120 Heidelberg
DE
Trademark representatives
Schreiberstr. 20
79098 Freiburg
DE
goods and services
05
Drugs; pharmaceutical and veterinary preparations;
diagnostic agents; pharmaceutical preparations; preparations
for medical purposes; preparations for biomedical purposes;
pharmaceutical cell preparations for medical use; substances
for medical use; substances for biomedical purposes; live
implants for pharmaceutical purposes; biochemical and
chemical products for medical use; biochemical and chemical
products for pharmaceutical purposes; biochemical and
chemical products for diagnostic purposes; proteins for
medical purposes; biological preparations for medical and
veterinary purposes, and pharmaceutical and veterinary
preparations, all for external use; biological,
pharmaceutical and veterinary preparations for skin care for
medical purposes; medical dressings; preparations for wound
treating and healing; biological, pharmaceutical and
veterinary preparations for the treatment of chronic wounds,
ulcers, burns and surgical wounds; stem cells for medical
purposes; stern cells for veterinary purposes; stern cells
for aesthetic purposes; somatic stem cell therapeutics;
fibroblasts for medical purposes; fibroblasts for aesthetic
purposes; pharmaceutical implants; surgical implants derived
from stem cells; surgical implants derived from fibroblasts;
biological tissue for implantation; growth media for
culturing cells for medical purposes; pharmaceutical
preparations for tissue regeneration; vascular grafts;
living tissue; biotechnologically engineered tissue
products
42
Pharmaceutical drug development; scientific and
technological services; research and development services in
the fields of cell diagnostics and therapy and surgical and
medical instruments; industrial analysis and research
services; scientific research for medical purposes; stem
cell research; scientific and medical research and
development; scientific research, testing and analysis
services; scientific research for medical purposes; medical
research; research in the field of biotechnology; research
in the field of gene therapy; research and development in
the field of immunology; research and development in the
field of antibodies; research and development in the field
of antibody technology; research and development in the
field of bacteriology; research and development in the field
of gene expression systems; research and development in the
field of vaccines; research and development services for the
pharmaceutical industry research and development services in
the field of biotechnology
44
Medical services; medical diagnostic services {carrying out
tests and analyses]; medical assistance; clinic services;
hospital services; plastic and cosmetic surgery; medical
therapies; medical services relating to the removal,
treatment, processing and storage of human cells and tissue,
stem cells and bone marrow, also in the field of
regenerative medicine, including tissue engineering; medical
services in connection with the removal, treatment,
processing and storage of human tissue and stem cells, also
in the field of regenerative medicine, including tissue
engineering; medical services relating to the cultivation
and procurement of stem cells; medical services in
connection with the cultivation and procurement of stem
cells
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 26, 2022 | 2022/35 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| July 27, 2022 | 2022/30 Gaz | Correction | |
| July 19, 2022 | 2022/29 Gaz | CA | Rejection |
| March 7, 2022 | 2022/10 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 22, 2022 | 2022/8 Gaz | CH | Rejection |
| August 18, 2021 | 2021/33 Gaz | GB | Rejection |
| August 10, 2021 | 2021/32 Gaz | EM | Rejection |
| August 2, 2021 | 2021/31 Gaz | RU | Rejection |
| July 15, 2021 | 2021/30 Gaz | CN | Rejection |
| June 9, 2021 | 2021/23 Gaz | AU | Rejection |
| June 9, 2021 | 2021/23 Gaz | US | Rejection |
| December 11, 2020 | 2021/9 Gaz | DE | Registration |
ID: 141581960